Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Hiroyu Hatano, MD, MHS

Title(s)Assistant Adjunct Professor, Cio
SchoolChancellor/EVC/FAS
AddressSFGH Bldg 80 Ward 84
Phone415-476-4082 ext. 122
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease. Nat Commun. 2024 11 18; 15(1):9966. Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso MJ, Martin J, Hecht F, Pilcher C, Cohen SE, Buchbinder S, Havlir D, Gandhi M, Henrich TJ, Hatano H, Wang J, Deeks SG, Lee SA. PMID: 39557853; PMCID: PMC11574060.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    2. Rapid Biphasic Decay of Intact and Defective HIV DNA Reservoir During Acute Treated HIV Disease. medRxiv. 2024 Aug 22. Barbehenn A, Shi L, Shao J, Hoh R, Hartig HM, Pae V, Sarvadhavabhatla S, Donaire S, Sheikhzadeh C, Milush J, Laird GM, Mathias M, Ritter K, Peluso MJ, Martin J, Hecht F, Pilcher C, Cohen SE, Buchbinder S, Havlir D, Gandhi M, Henrich TJ, Hatano H, Wang J, Deeks SG, Lee SA. PMID: 38585951; PMCID: PMC10996734.
      View in: PubMed   Mentions:
    3. An Improved Backoff Scheme and Its Performance Analysis for Full Duplex MAC Protocols in VLC Networks. Sensors (Basel). 2021 Dec 10; 21(24). Sawa Y, Sanada K, Hatano H, Mori K. PMID: 34960370; PMCID: PMC8706655.
      View in: PubMed   Mentions:    Fields:    
    4. Gag p24 Is a Marker of Human Immunodeficiency Virus Expression in Tissues and Correlates With Immune Response. J Infect Dis. 2021 11 16; 224(9):1593-1598. Wu G, Zuck P, Goh SL, Milush JM, Vohra P, Wong JK, Somsouk M, Yukl SA, Shacklett BL, Chomont N, Haase AT, Hatano H, Schacker TW, Deeks SG, Hazuda DJ, Hunt PW, Howell BJ. PMID: 33693750; PMCID: PMC8599810.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    5. Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay. J Acquir Immune Defic Syndr. 2020 04 15; 83(5):530-537. Lee SA, Telwatte S, Hatano H, Kashuba ADM, Cottrell ML, Hoh R, Liegler TJ, Stephenson S, Somsouk M, Hunt PW, Deeks SG, Yukl S, Savic RM. PMID: 32168200; PMCID: PMC7286563.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    6. Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites. J Virol. 2020 01 17; 94(3). Lee E, von Stockenstrom S, Morcilla V, Odevall L, Hiener B, Shao W, Hartogensis W, Bacchetti P, Milush J, Liegler T, Sinclair E, Hatano H, Hoh R, Somsouk M, Hunt P, Boritz E, Douek D, Fromentin R, Chomont N, Deeks SG, Hecht FM, Palmer S. PMID: 31723024; PMCID: PMC7000983.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    7. Gut and blood differ in constitutive blocks to HIV transcription, suggesting tissue-specific differences in the mechanisms that govern HIV latency. PLoS Pathog. 2018 11; 14(11):e1007357. Telwatte S, Lee S, Somsouk M, Hatano H, Baker C, Kaiser P, Kim P, Chen TH, Milush J, Hunt PW, Deeks SG, Wong JK, Yukl SA. PMID: 30440043; PMCID: PMC6237391.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    8. Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir? J Infect Dis. 2018 03 13; 217(7):1024-1032. Burbelo PD, Price RW, Hagberg L, Hatano H, Spudich S, Deeks SG, Gisslén M. PMID: 29401308; PMCID: PMC5939835.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    9. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study. PLoS Med. 2017 Nov; 14(11):e1002417. Henrich TJ, Hatano H, Bacon O, Hogan LE, Rutishauser R, Hill A, Kearney MF, Anderson EM, Buchbinder SP, Cohen SE, Abdel-Mohsen M, Pohlmeyer CW, Fromentin R, Hoh R, Liu AY, McCune JM, Spindler J, Metcalf-Pate K, Hobbs KS, Thanh C, Gibson EA, Kuritzkes DR, Siliciano RF, Price RW, Richman DD, Chomont N, Siliciano JD, Mellors JW, Yukl SA, Blankson JN, Liegler T, Deeks SG. PMID: 29112956; PMCID: PMC5675377.
      View in: PubMed   Mentions: 146     Fields:    Translation:HumansCellsPHPublic Health
    10. A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals. Pathog Immun. 2017; 2(3):310-334. Cockerham LR, Yukl SA, Harvill K, Somsouk M, Joshi SK, Sinclair E, Liegler T, Hoh R, Lyons S, Hunt PW, Rupert A, Sereti I, Morcock DR, Rhodes A, Emson C, Hellerstein MK, Estes JD, Lewin S, Deeks SG, Hatano H. PMID: 28936485; PMCID: PMC5604865.
      View in: PubMed   Mentions: 4  
    11. Corrigendum: Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2017 04 06; 544(7648):124. Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Zepeda O, Hunt PW, Hatano H, Sowinski S, Muñoz-Arias I, Greene WC. PMID: 28329768.
      View in: PubMed   Mentions: 13     Fields:    
    12. The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting. J Acquir Immune Defic Syndr. 2017 Jan 01; 74(1):44-51. Pilcher CD, Ospina-Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, Calderon F, Demicco E, Geng E, Gandhi M, Havlir DV, Hatano H. PMID: 27434707; PMCID: PMC5140684.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCells
    13. Immunologic profiles distinguish aviremic HIV-infected adults. AIDS. 2016 06 19; 30(10):1553-62. Ramirez CM, Sinclair E, Epling L, Lee SA, Jain V, Hsue PY, Hatano H, Conn D, Hecht FM, Martin JN, McCune JM, Deeks SG, Hunt PW. PMID: 26854811; PMCID: PMC5679214.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    14. Post-Treatment Controllers: Role in HIV "Cure" Research. Curr HIV/AIDS Rep. 2016 Feb; 13(1):1-9. Cockerham LR, Hatano H, Deeks SG. PMID: 26781112.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    15. Clinical outcomes and antiretroviral therapy in 'elite' controllers: a review of the literature. J Virus Erad. 2015 Apr; 1(2):72-77. Crowell TA, Hatano H. PMID: 27123315; PMCID: PMC4844069.
      View in: PubMed   Mentions: 16  
    16. Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy. J Infect Dis. 2015 Aug 15; 212(4):596-607. von Stockenstrom S, Odevall L, Lee E, Sinclair E, Bacchetti P, Killian M, Epling L, Shao W, Hoh R, Ho T, Faria NR, Lemey P, Albert J, Hunt P, Loeb L, Pilcher C, Poole L, Hatano H, Somsouk M, Douek D, Boritz E, Deeks SG, Hecht FM, Palmer S. PMID: 25712966; PMCID: PMC4539896.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansCells
    17. Elite control of HIV: is this the right model for a functional cure? Trends Microbiol. 2015 Feb; 23(2):71-5. Cockerham LR, Hatano H. PMID: 25487109.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    18. Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions. J Infect Dis. 2015 Apr 01; 211(7):1068-75. Sanchez JL, Hunt PW, Reilly CS, Hatano H, Beilman GJ, Khoruts A, Jasurda JS, Somsouk M, Thorkelson A, Russ S, Anderson J, Deeks SG, Schacker TW. PMID: 25344521; PMCID: PMC4416122.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    19. Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease. AIDS. 2014 Jul 31; 28(12):1749-58. Cockerham LR, Jain V, Sinclair E, Glidden DV, Hartogenesis W, Hatano H, Hunt PW, Martin JN, Pilcher CD, Sekaly R, McCune JM, Hecht FM, Deeks SG. PMID: 24871455; PMCID: PMC4206412.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    20. HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014 May; 10(5):e1004078. Serrano-Villar S, Sainz T, Lee SA, Hunt PW, Sinclair E, Shacklett BL, Ferre AL, Hayes TL, Somsouk M, Hsue PY, Van Natta ML, Meinert CL, Lederman MM, Hatano H, Jain V, Huang Y, Hecht FM, Martin JN, McCune JM, Moreno S, Deeks SG. PMID: 24831517; PMCID: PMC4022662.
      View in: PubMed   Mentions: 347     Fields:    Translation:HumansCells
    21. Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging. PLoS One. 2014; 9(2):e89444. Lee SA, Sinclair E, Hatano H, Hsue PY, Epling L, Hecht FM, Bangsberg DR, Martin JN, McCune JM, Deeks SG, Hunt PW. PMID: 24586783; PMCID: PMC3937334.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    22. A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells. AIDS. 2014 Jan 28; 28(3):439-42. Yukl SA, Sinclair E, Somsouk M, Hunt PW, Epling L, Killian M, Girling V, Li P, Havlir DV, Deeks SG, Wong JK, Hatano H. PMID: 24322272; PMCID: PMC4130176.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    23. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014 Jan 23; 505(7484):509-14. Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Zepeda O, Hunt PW, Hatano H, Sowinski S, Muñoz-Arias I, Greene WC. PMID: 24356306; PMCID: PMC4047036.
      View in: PubMed   Mentions: 624     Fields:    Translation:HumansCells
    24. Reply to Karch et al. J Infect Dis. 2014 Jul 01; 210(1):159-60. Hatano H, Bacchetti P, Hsue PY, Deeks SG. PMID: 24421253; PMCID: PMC4161999.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    25. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog. 2013; 9(10):e1003691. Hatano H, Yukl SA, Ferre AL, Graf EH, Somsouk M, Sinclair E, Abdel-Mohsen M, Liegler T, Harvill K, Hoh R, Palmer S, Bacchetti P, Hunt PW, Martin JN, McCune JM, Tracy RP, Busch MP, O'Doherty U, Shacklett BL, Wong JK, Deeks SG. PMID: 24130489; PMCID: PMC3795031.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCellsCTClinical Trials
    26. Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers. AIDS. 2013 Sep 10; 27(14):2255-60. Hatano H, Somsouk M, Sinclair E, Harvill K, Gilman L, Cohen M, Hoh R, Hunt PW, Martin JN, Wong JK, Deeks SG, Yukl SA. PMID: 24157906; PMCID: PMC4143147.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    27. Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial. J Infect Dis. 2013 Nov 01; 208(9):1436-42. Hatano H, Strain MC, Scherzer R, Bacchetti P, Wentworth D, Hoh R, Martin JN, McCune JM, Neaton JD, Tracy RP, Hsue PY, Richman DD, Deeks SG. PMID: 23975885; PMCID: PMC3789577.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCells
    28. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size. J Infect Dis. 2013 Oct 15; 208(8):1202-11. Jain V, Hartogensis W, Bacchetti P, Hunt PW, Hatano H, Sinclair E, Epling L, Lee TH, Busch MP, McCune JM, Pilcher CD, Hecht FM, Deeks SG. PMID: 23852127; PMCID: PMC3778965.
      View in: PubMed   Mentions: 204     Fields:    Translation:HumansCells
    29. Immune activation and HIV persistence: considerations for novel therapeutic interventions. Curr Opin HIV AIDS. 2013 May; 8(3):211-6. Hatano H. PMID: 23454864; PMCID: PMC4041488.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    30. A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection. J Acquir Immune Defic Syndr. 2012 Nov 01; 61(3):317-25. Hatano H, Scherzer R, Wu Y, Harvill K, Maka K, Hoh R, Sinclair E, Palmer S, Martin JN, Busch MP, Deeks SG, Hsue PY. PMID: 22918156; PMCID: PMC3480968.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    31. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J Infect Dis. 2013 Jul; 208(1):50-6. Hatano H, Jain V, Hunt PW, Lee TH, Sinclair E, Do TD, Hoh R, Martin JN, McCune JM, Hecht F, Busch MP, Deeks SG. PMID: 23089590; PMCID: PMC3666131.
      View in: PubMed   Mentions: 175     Fields:    Translation:HumansCells
    32. Prolonged and substantial discordance in prevalence of raltegravir-resistant HIV-1 in plasma versus PBMC samples revealed by 454 "deep" sequencing. PLoS One. 2012; 7(9):e46181. Lee GQ, Swenson LC, Poon AF, Martin JN, Hatano H, Deeks SG, Harrigan PR. PMID: 23049972; PMCID: PMC3458959.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    33. Prevalence and significance of HIV-1 drug resistance mutations among patients on antiretroviral therapy with detectable low-level viremia. Antimicrob Agents Chemother. 2012 Nov; 56(11):5998-6000. Li JZ, Gallien S, Do TD, Martin JN, Deeks S, Kuritzkes DR, Hatano H. PMID: 22890763; PMCID: PMC3486544.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    34. A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response. J Infect Dis. 2011 Apr 01; 203(7):960-8. Hatano H, Hayes TL, Dahl V, Sinclair E, Lee TH, Hoh R, Lampiris H, Hunt PW, Palmer S, McCune JM, Martin JN, Busch MP, Shacklett BL, Deeks SG. PMID: 21402547; PMCID: PMC3068029.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansCells
    35. A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One. 2011 Jan 31; 6(1):e15924. Hunt PW, Landay AL, Sinclair E, Martinson JA, Hatano H, Emu B, Norris PJ, Busch MP, Martin JN, Brooks C, McCune JM, Deeks SG. PMID: 21305005; PMCID: PMC3031543.
      View in: PubMed   Mentions: 83     Fields:    Translation:Cells
    36. HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers. Clin Infect Dis. 2011 Mar 01; 52(5):681-7. Hunt PW, Hatano H, Sinclair E, Lee TH, Busch MP, Martin JN, McCune JM, Deeks SG. PMID: 21245154; PMCID: PMC3060894.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    37. Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals. AIDS. 2010 Oct 23; 24(16):2535-9. Hatano H, Delwart EL, Norris PJ, Lee TH, Neilands TB, Kelley CF, Hunt PW, Hoh R, Linnen JM, Martin JN, Busch MP, Deeks SG. PMID: 20651585; PMCID: PMC2954261.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    38. Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes. J Virol Methods. 2010 Dec; 170(1-2):115-20. Li P, Ruel T, Fujimoto K, Hatano H, Yukl S, Eller LA, Liegler T, Kamya M, Gassasira A, Dorsey G, Rosenthal PJ, Havlir DV, Wong JK. PMID: 20863855; PMCID: PMC3280821.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    39. Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy. J Acquir Immune Defic Syndr. 2010 Aug; 54(4):389-93. Hatano H, Lampiris H, Fransen S, Gupta S, Huang W, Hoh R, Martin JN, Lalezari J, Bangsberg D, Petropoulos C, Deeks SG. PMID: 20300008; PMCID: PMC2890029.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    40. Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients. AIDS. 2009 Sep 24; 23(15):2021-7. Hsue PY, Hunt PW, Wu Y, Schnell A, Ho JE, Hatano H, Xie Y, Martin JN, Ganz P, Deeks SG. PMID: 19542863; PMCID: PMC2785446.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    41. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol. 2009 Jan; 83(1):329-35. Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, Hoh R, Stramer SL, Linnen JM, McCune JM, Martin JN, Busch MP, Deeks SG. PMID: 18945778; PMCID: PMC2612329.
      View in: PubMed   Mentions: 126     Fields:    Translation:HumansCells
    42. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control. J Virol. 2008 Jun; 82(11):5398-407. Emu B, Sinclair E, Hatano H, Ferre A, Shacklett B, Martin JN, McCune JM, Deeks SG. PMID: 18353945; PMCID: PMC2395228.
      View in: PubMed   Mentions: 151     Fields:    Translation:HumansCells
    43. Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase. J Acquir Immune Defic Syndr. 2007 Aug 15; 45(5):494-500. Hu Z, Hatano H, Hammond SP, Smith D, Wild M, Gupta S, Whitcomb J, Kalayjian RC, Gripshover B, Kuritzkes DR. PMID: 17496561.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    44. Drug resistant HIV. BMJ. 2007 Jun 02; 334(7604):1124-5. Hatano H, Deeks SG. PMID: 17540912; PMCID: PMC1885311.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Vibrational relaxation of O2(X3 Sigma g-, v = 9-13) by collisions with O2. Phys Chem Chem Phys. 2007 Aug 21; 9(31):4407-13. Watanabe S, Usuda SY, Fujii H, Hatano H, Tokue I, Yamasaki K. PMID: 17687487.
      View in: PubMed   Mentions:    Fields:    
    46. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen. Clin Infect Dis. 2006 Nov 15; 43(10):1329-36. Hatano H, Hunt P, Weidler J, Coakley E, Hoh R, Liegler T, Martin JN, Deeks SG. PMID: 17051502.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    47. Fitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1. J Virol. 2006 Jul; 80(14):7020-7. Hu Z, Giguel F, Hatano H, Reid P, Lu J, Kuritzkes DR. PMID: 16809307; PMCID: PMC1489059.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    Hiroyu's Networks
    Concepts (181)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (43)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.